Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia
1 other identifier
observational
35
1 country
1
Brief Summary
Schizophrenia is a serious mental health condition that affects individuals' thinking, perception, emotional responses, and behavior. Balance in schizophrenia patients is often related to motor skills, coordination, and postural control. Schizophrenia can cause functional changes in certain areas of the brain. These changes can affect motor functions. Balance loss in schizophrenia patients can cause difficulties in daily living activities, increased risk of falls, and a decrease in overall quality of life. Therefore, the aim of this study is to evaluate physical activity, balance, muscle strength, and cognitive function in patients diagnosed with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedStudy Start
First participant enrolled
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
August 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedAugust 19, 2026
August 1, 2025
11 days
August 19, 2025
August 17, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
International Physical Activity Questionnaire (IPAQ):
Used to assess an individual's physical activity level over the past 7 days. The International Physical Activity Questionnaire (IPAQ) consists of 4 questionnaires. There are long (5 independently asked activity areas) and short (4 general items) versions. The short version consists of questions about the time spent walking and engaging in moderate to vigorous and strenuous activities.
2 weeks
Berg Balance Scale
Berg Balance Scale The scale, consisting of a total of 14 items, assesses patients' balance skills. Each item is scored on a scale of 0-4. 0 = unable to perform, 4 = normal performance. The maximum score is 56, and a high score indicates better balance skills. The physical therapist administers the test by providing the necessary instructions to the patient in a manner they can understand after the patient has rested. The choice of which foot to use in certain items should be left to the patient. The materials required for the test (stopwatch, measuring tape, chair, step, slippers) should be prepared before beginning the assessment.
2 weeks
Handgrip Strength
Handgrip strength was assessed using the JTech Commander GripTrack™ hand dynamometer. Participants performed the measurement according to a standardized testing procedure, and grip strength was recorded in kilograms (kg). Higher values indicate greater handgrip strength.
2 weeks
Mini Mental State Examination
The standardized version of the MMSE (Mini Mental State Examination) developed by Folstein et al. (1975) was adapted by Molloy and Standish (1997). The MMSE allows for cognitive assessment in a short period of time. In this regard, the MMSE is a short, easy-to-administer, and standardized test used to assess global cognitive level. The test is widely used to evaluate the cognitive status of elderly individuals. A validity and reliability study in the Turkish population was conducted by Güngen and colleagues (2002). In their study, Güngen and colleagues (2002) determined that the 23/24 cutoff value of the Standardized Mini Mental Test (SMMT) had a sensitivity of 0.91, a specificity of 0.95, an inter-rater reliability of r:0.99, and a kappa value of 0.92. As a result, it was determined that the Standardized Mini Mental Test is valid and reliable in the Turkish population.
2 weeks
Study Arms (1)
patients with schizophrenia
patients with schizophrenia
Eligibility Criteria
Patients with Schizophrenia
You may qualify if:
- Diagnosis of schizophrenia by a psychiatrist according to DSM-V
- aged between 18 and 65 years
- being clinically stable
- having received continuous pharmacological treatment for at least six months
- having the ability to understand and follow verbal and written instructions
You may not qualify if:
- major neurological disorders (e.g. epilepsy or Parkinson's disease)
- significant orthopaedic impairments affecting balance or strength
- substance use disorders (except nicotine)
- acute psychotic symptoms and severe intellectual disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kartal Dr Lütfi Kırdar City Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Prof
Study Record Dates
First Submitted
August 19, 2025
First Posted
August 26, 2025
Study Start
August 19, 2025
Primary Completion
August 30, 2025
Study Completion
September 15, 2025
Last Updated
August 19, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share